Bhowmick, Tanaya; Canton, Rafael; Pea, Federico; Quevedo, Juan; Santerre Henriksen, Anne; Timsit, Jean-François; Kaye, Keith S, Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales, «FUTURE MICROBIOLOGY», in corso di stampa, Online ahead of print, pp. 1 - 10 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, pp. 1 - 12 [Scientific article]Open Access
Gatti, M.; Rinaldi, M.; Bonazzetti, C.; Siniscalchi, A.; Tonetti, T.; Ambretti, S.; Giannella, M.; Viale, P.; Pea, F., A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar?, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1543 - 1551 [Scientific article]Open Access
Cojutti, Pier Giorgio; Tedeschi, Sara; Zamparini, Eleonora; Fornaro, Giacomo; Zagarrigo, Manuel; De Paolis, Massimiliano; Viale, Pierluigi; Pea, Federico, Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?, «ANTIBIOTICS», 2025, 14, Article number: 139 , pp. 1 - 14 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2025, N/A, pp. 1 - 37 [Scientific article]
Bhakta, Sanjib; Xie, Jianping; Pea, Federico; Gillespie, Stephen H., Data transparency and reproducibility in health research: bridging the gap for early-career researchers, «FRONTIERS IN ANTIBIOTICS», 2025, 4, Article number: 1562002 , pp. 1 - 6 [Scientific article]Open Access
Babich, Stella; Cojutti, Pier Giorgio; Gatti, Milo; Pea, Federico; Di Bella, Stefano; Monticelli, Jacopo, Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis, «JAC-ANTIMICROBIAL RESISTANCE», 2025, 7, Article number: dlaf066 , pp. 1 - 4 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Ambretti, Simone; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1153 - 1155 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Bonazzetti, Cecilia; Vizioli, Luca; Ambretti, Simone; Morelli, Maria Cristina; Siniscalchi, Antonio; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study, «THE JOURNAL OF INFECTIOUS DISEASES», 2025, N/A, pp. 1 - 11 [Scientific article]
Cojutti, Pier Giorgio; Pea, Federico, Is it Time to Move From Intermittent to Continuous Infusion Administration of Vancomycin?, «OPEN FORUM INFECTIOUS DISEASES», 2025, 12, pp. 1 - 2 [Comment or similar]Open Access
Giacometti, Tommaso; Rocchi, Ettore; Cojutti, Pier Giorgio; Magnani, Federico; Remondini, Daniel; Pea, Federico; Castellani, Gastone, Leveraging Neural ODEs for Population Pharmacokinetics of Dalbavancin in Sparse Clinical Data, «ENTROPY», 2025, 27, Article number: 602 , pp. 1 - 16 [Scientific article]Open Access
Marcheggiani Muccioli, Giulio Maria; Zamparini, Eleonora; Fogacci, Alberto; Grechi, Andrea; Pea, Federico; Viale, Pierluigi; Zaffagnini, Stefano, Methicillin-resistant Staphylococcus epidermidis knee prosthetic infection treatment with two-stage revision and fosfomycin–rifampin combination therapy: a case report, «JOURNAL OF MEDICAL CASE REPORTS», 2025, 19, Article number: 55 , pp. 1 - 10 [Scientific article]Open Access
Tonetti, Tommaso; Gatti, Milo; Pea, Federico, Personalizing beta-lactams therapy in critical patients undergoing RRT: moving a further step forward?, «INTENSIVE CARE MEDICINE», 2025, 10.1007/s00134-025-08165-9, pp. 1 - 2 [Comment or similar]
Ambretti, Simone; Secci, Benedetta; Cetatean, Raul; Gatti, Milo; Viale, Pierluigi; Pea, Federico; Foschi, Claudio, Rapid Emergence of Cefiderocol Resistance Associated with Mutation of EnvZ Gene in a VIM-Producing ST307 Klebsiella pneumoniae Strain, «ANTIBIOTICS», 2025, 14, Article number: 893 , pp. 1 - 9 [Scientific article]Open Access
Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, Role of a TDM-guided strategy of isavuconazole for optimizing efficacy/safety outcomes in onco-hematological pediatric patients: a systematic review, «CHEMOTHERAPY», 2025, 10.1159/000547799, pp. 1 - 24 [Scientific article]
